Welcome to our dedicated page for Charles & Colvard news (Ticker: CTHR), a resource for investors and traders seeking the latest updates and insights on Charles & Colvard stock.
Charles & Colvard Ltd (CTHR) delivers lab-created moissanite gemstones and fine jewelry through innovative manufacturing and ethical practices. This news hub provides investors and industry observers with official press releases and verified updates about the company's operations.
Access real-time information on financial results, product innovations, and strategic initiatives in the moissanite jewelry sector. Key updates include earnings announcements, retail partnerships, sustainability progress, and technological advancements in gemstone production.
Discover comprehensive coverage of CTHR's dual-channel distribution strategy, including developments in their digital B2B trade portal and traditional retail collaborations. Content spans operational milestones, quality assurance enhancements, and market expansion efforts within the ethical jewelry space.
Bookmark this page for streamlined access to Charles & Colvard's latest corporate communications. Monitor how the company maintains its leadership position through silicon carbide innovation and responsible business practices in the evolving fine jewelry market.
Charles & Colvard (Nasdaq: CTHR) has launched its first line of men's diamond fashion bands featuring Caydia® lab-grown diamonds and 14K recycled gold. This new collection, part of the Signature Collection, aims to expand their market presence in lab-grown diamond jewelry. CEO Don O'Connell emphasized the brand's commitment to combining traditional design with modern aesthetics. The company aims to be a leading destination for lab-grown diamond jewelry, reinforcing their ethical stance of using exclusively Made, Not Mined™ gemstones.
Charles & Colvard reported $9.3 million in net sales for Q4 FY 2022, a 4% decline year-over-year. However, the company achieved a record $43.1 million in net sales for FY 2022, a 10% increase from the previous year. Lab-grown diamond sales soared by 173%, while moissanite sales grew by 13%. The firm recorded a gross margin of 47% and $2.4 million in net income, translating to $0.08 earnings per diluted share. Cash reserves stood strong at $21.2 million. The company maintained profitability over eight consecutive quarters.
Charles & Colvard, Ltd. (Nasdaq: CTHR) will host an investor conference call on September 1, 2022, at 4:30 p.m. ET to discuss its financial results for the fourth quarter and fiscal year ending June 30, 2022. The financial results will be released after market close on the same day. Interested participants can join via telephone or access the live webcast through the Investor Relations section of the company's website. A replay will be available until September 8, 2022.
Charles & Colvard, Ltd. (Nasdaq: CTHR) unveils its new Couture Collection, featuring 50 pieces of luxury jewelry made with Caydia® lab-grown diamonds and recycled metals. Highlights include stunning 10-carat earrings and 12-carat tennis bracelets aimed at luxury consumers. CEO Don O'Connell emphasizes a commitment to responsible luxury, aiming to redefine high couture jewelry. The collection showcases diverse gemstone cuts and signifies the company's leadership in lab-grown gems. Consumers can explore the Couture Collection on their website.
Charles & Colvard reported $9.8 million in net sales for the quarter ended March 31, 2022, marking a 3% increase year-over-year. The company generated $1.1 million in cash flow from operations and increased total cash to $21.9 million. A new $5 million stock buyback program was announced, demonstrating confidence in the company's direction. Revenue growth was primarily driven by a 141% surge in lab-grown diamond sales and a 10% increase in moissanite sales. However, operating expenses rose 22% to $4 million.
Charles & Colvard (Nasdaq: CTHR) has entered a strategic distribution agreement with Cooksongold, a leading wholesale jewelry supplier in the UK. This partnership aims to expand Charles & Colvard's presence in Europe, specifically for their Forever One moissanite and Moissanite by Charles & Colvard brands. Customers will benefit from next-day delivery options, highlighting the company's commitment to sustainability and increased accessibility to lab-grown gemstones.
Charles & Colvard, Ltd. (Nasdaq: CTHR), a leader in lab-grown gemstones, plans to host an investor conference call on May 5, 2022, at 8:00 a.m. ET to discuss its financial results for the third quarter of fiscal year 2022, ending March 31, 2022. The earnings report will be released before the market opens that day. The call will be accessible via a live webcast on the company’s Investor Relations page.
Charles & Colvard, Ltd. (Nasdaq: CTHR) will host an investor conference call to discuss its financial results for the third quarter of fiscal year 2022 on May 5, 2022, at 8:00 a.m. ET. The financial results will be released after the market closes on the same day. Investors can access the call via webcast on the Company's Investor Relations website or participate via telephone. A replay will be available until May 12, 2022. Charles & Colvard specializes in lab-grown gemstones, offering the Forever One moissanite and Caydia lab-grown diamonds.
Charles & Colvard, Ltd. (CTHR) reported a record revenue of $13.8 million for Q2 FY2022, a 13% increase year-over-year, with a 49% gross margin. Year-to-date revenue reached $24.0 million, up 20% compared to the previous year. Direct-to-consumer sales jumped nearly 50%, while total online sales comprised 68% of net sales. Operating income was $1.5 million with earnings per diluted share at $0.04. Operating expenses rose 52% to $5.3 million, impacting net income, which declined 41% to $1.2 million. Cash equivalents stood at $21.3 million.
Charles & Colvard, Ltd. (Nasdaq: CTHR) will host an investor conference call on February 3, 2022, at 4:30 p.m. ET to discuss its financial results for the quarter ending December 31, 2021. The financial results will be released after market close on the same day. Investors can join the call by dialing the provided numbers or accessing the webcast on the company’s Investor Relations website. A replay will be available until February 10, 2022.